Table 4.
Post‐operative findings and adverse cardiac events
| Post‐operative finding | N = 1272 (%) |
|---|---|
| Low‐output syndrome | 360 (28.3) |
| Use of catecholamines | |
| Norepinephrine | 392 (31) |
| Dobutamine | 782 (61.7) |
| Epinephrine | 293 (23.2) |
| Time of inotropic support (days) | |
| Norepinephrine | 6.18 ± 9.9 |
| Epinephrine | 1.57 ± 4.5 |
| Use of blood/products (mL) | |
| PRBC | 1501 ± 1388 |
| FFP | 514 ± 834 |
| Thrombocytes | 443 ± 424 |
| ICU characteristics | |
| ICU stay (days) | 9.64 ± 16.61 |
| Intubation time (h) | 140 ± 267 |
| Post‐operative bleeding | 239 (18.8) |
| Need for surgical re‐exploration | 69 (5.4) |
| CPR | 104 (8.2) |
| Infection | 623 (49) |
| Cerebrovascular event | 37 (2.9) |
| Re‐intubation | 139 (10.9) |
| New onset dialysis | 425 (33.4) |
| AF | 640 (50.3) |
| Post‐operative laboratory findings | |
| INR | 1.2 ± 0.37 |
| Creatinine (mg/dL) | 1.84 ± 1.19 |
| Bilirubin (mg/L) | 6.51 ± 7.69 |
| Time to maximum bilirubin concentration (days) | 4.7 ± 10.2 |
| In‐hospital mortality | 221 (17.4) |
AF, atrial fibrillation; CPR, cardiopulmonary resuscitation; FFP, fresh frozen plasma; ICU, intensive care unit; INR, international normalized ratio; PRBC, packed red blood cell.